Jonathan Baden

4PUBLICATIONS
14CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 11, 2026
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0.

|Jul 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915.

Georgina V Long, Hao Tang, Keyur Desai

|Aug 06, 2024
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.

Michael Schenker, Mauricio Burotto, Martin Richardet

|Nov 30, 2023
Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMB.

Jie He, Natallia Kalinava, Parul Doshi

Pageof 1

Frequent Collaborators

1 joint publications

Ericka M Ebot

1 joint publications

Paolo A Ascierto

1 joint publications

Massimo Di Nicola

1 joint publications

Sonia Dolfi